Figure 1

MyPEAK-1 Change in LVMI

Treatment with TN-201 gene therapy resulted in decreased hypertrophy in patients with MYPBC3-associated HCM

Format

JPEG

Source

Tenaya Therapeutics, Inc.

Downloads